Mylan and Teva are among a group of generic drugmakers that got antitrust clearance from EU cartel rules for a project to produce critical hospital medicines in short supply amid the Covid-19 pandemic

Mylan and Teva are among a group of generic drugmakers that got antitrust clearance from EU cartel rules for a project to produce critical hospital medicines in short supply amid the Covid-19 pandemic https://t.co/ETFQb6ZHNe

— Bloomberg Markets (@markets) April 8, 2020